DOCSLIB.ORG

Synbiotics – a Promising Approach for the Primary Prevention and Dietary

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Synbiotics – a Promising Approach for the Primary Prevention and Dietary Sponsored Content Synbiotics may rebalance the gut microbiota in Caesarian-section PREBIOTIC PROBIOTIC infants and reduce severity of atopic dermatitis in infants fibres which live beneficial The results of the JULIUS Study showed that a formula supplemented stimulate the bacteria with synbiotics (scGOS/lcFOS/B. breve M-16V) re-established growth and the delayed colonisation of Bifidobacterium in Caesarian-section Synbiotics – a promising approach activity of delivered infants, from the first days of life and provided the beneficial bacteria SYNBIOTIC physiological conditions for a healthy gut, as observed in vaginally Pre- and born infants. Exploratory data suggested a potential protective for the primary prevention and dietary Probiotic blend effect on adverse events related to skin disorders and atopic management of cow’s milk allergy dermatitis (AD) early in life.21 The SYNBAD Study confirmed the bifidogenic capacity of this synbiotic blend in infants with AD. In addition, the synbiotic (EHF) reduced AD severity within the subgroup of infants with IgE Nutricia presents the final installment in a three-part series of discussions around associated AD, and improved diaper/nappy dermatitis symptoms.12 The 1 year follow-up data also showed reduced prevalence of allergies in early life. This article focuses on synbiotics, a promising approach for 13 Synbiotics can be used to target microbial dysbiosis in the primary asthma-like symptoms and medication use in infants with AD. primary prevention and dietary management of cow’s milk allergy (CMA). prevention and dietary management of cow’s milk allergy. Synbiotics are safe, hypoallergenic and improve the microbiota of PREBIOTIC PROBIOTIC infants with CMA scFOS/lcFOS and Bifidobacterium breve Clinical studies have shown that an AAF with synbiotics is The global rise of allergy scGOS/lcFOS M-16V hypoallergenic, well tolerated and supports normal growth in both 22-24 The prevalence of allergic diseases, such as food allergy, atopic eczema, allergic rhinitis and asthma, is rising healthy and CMA infants. The ASSIGN study investigated the • Feeds the proliferation of • A commonly isolated Bifidobacteria effects of an AAF including synbiotics (scFOS/lcFOS/B. breve M-16V) 1 18 dramatically worldwide. CMA is one of the most common allergies in infants and young children, affecting Bifidobacteria species in human milk on percentages of Bifidobacteria and Eubacterium rectale/Clostridium up to 5% of the world population.2 • Widely studied prebiotic • M-16V, selected among 400 coccoides (ER/CC) in feces from infants with suspected non-IgE mixture in infants different strains mediated CMA. Feces from age matched healthy breastfed reference • Clinically shown to mimic • Safe, free from major allergens19 group were also collected. An eight week intervention with an AAF The importance of the gut microbiota in early life immune modulating and • Clinically shown to have immune- with these specific synbiotics was shown to lead to increased levels of bifidogenic effects modulating effect "infant like" Bifidobacteria and decreased “adult like” ER/CC compared The immune system develops quickly during Environmental factors such as mode of potentially giving rise to allergic diseases.4 17 of human milk to an AAF without synbiotics. These bacterial changes approximated the first 1000 days of life; it is well known delivery, diet and use of antibiotics influence For this reason, targeting the gut microbiota • Has a synergistic effect with GOS/ the levels in the healthy breastfed group. This supports the hypothesis that both the establishment and maintenance the infant gut and immune system. These is suggested to be important in reducing FOS, FOS/FOS modulating the gut microbiota19 that an AAF with synbiotics improves the fecal microbiota of infants of an optimal microbial community is factors can cause an imbalance of the gut the risk or persistence of allergic diseases with suspected non-IgE medicated CMA.14 important for the development of the microbiota known as dysbiosis, which impairs like CMA.5 immune system and essential to maintain the development of the immune system, The ongoing PRESTO study includes infants with confirmed health, especially in infants and children.3 resulting in a state of inflammation and Scientific substantiation of the synbiotic IgE-mediated CMA, randomly allocated to receive the same AAF concept for allergy management with or without synbiotics for 12 months and will assess cow’s milk tolerance acquisition over 12, 24 and 36 months. This trial will inform The synbiotic concept Nutricia has undertaken an extensive clinical research programme to future studies primarily focusing on the clinical outcomes in the Synbiotics are a combination of pre- and healthy infants.9 Human milk contains human “Synbiotics are clinically support the safety, tolerability and efficacy of the synbiotic concept: specific CMA populations. probiotics.6 Pre- and probiotics can influence milk oligosaccharides (HMOs) and live bacteria the immune system directly, or indirectly, that are provided at a critical stage in the early proven to influence the via the gut microbiota, and therefore they development of the gut microbiota.10 Future of allergy management for CMA patients may play a role in preventing the onset of an gut microbiota, offering The dramatic increase in allergic disease be a new way to reduce the incidence and underway investigating the role of these 7 allergic disease. The objective of combining Given the presence and important role of requires a new focus on strategies for persistence of allergic diseases like CMA. ingredients in the primary prevention and pre- and probiotics is to achieve stronger these naturally occurring pre- and probiotics, important opportunities the primary prevention and dietary dietary management of CMA. positive effects than with either component and recognising that breast feeding is management of food allergy. Increasing Nutricia believes that there is a strong 8 in the management of alone (synergy). not always possible, there is a compelling insights have highlighted the importance rationale to include pre-, pro- and Nutricia continues to collaborate with rationale to combine pre- and probiotic cow’s milk allergy” of the gut microbiota for overall health and synbiotics in the diet of these infants and global experts to further its understanding The gut microbiota of infants with allergic ingredients (synbiotics) in infant formula so targeting the gut microbiota appears to has an extensive clinical trial programme of the impact of nutrition on food allergy. conditions is characterized by low levels of that functionally it more closely resembles Professor Jan Knol Bifidobacteria and Lactobacilli compared with human breast milk. Gut Biology & Microbiology, Nutricia Research For more information visit www.nutriciaresearch.com/allergy/ References: 1. Pawankar R, et al. World Allergy Organisation (WOA): White 10. Walker WA, et al. Breast milk, microbiota, and intestinal 18. Martin, R., et al., Isolation of bifidobacteria from breast book on allergy. Wisconsin: World Allergy Organization, 2011. immune homeostasis. Pediatr Res, 2015; 77(1–2): milk and assessment of the bifidobacterial population by Synbiotics as a promising approach for CMA 2. Fiocchi A, et al. World Allergy Organization (WAO) Diagnosis 220–228. PCR-denaturing gradient gel electrophoresis and quantitative and Rationale for Action against Cow’s Milk Allergy (DRACMA) 11. Boyle R et al. Prebiotic-supplemented partially hydrolysed real-time PCR. Appl Environ Microbiol, 2009. 75(4): p. 965-9. A growing amount of clinical evidence shows Supplementation with specific prebiotic hydrolysates may contribute to the induction Guidelines. Pediatr Allergy Immunol 2010: 21 (Suppl. 21): cow’s milk formula for the prevention of eczema in high-risk 19. Hougee S et al, Oral treatment with probiotics reduces allergic that pre- and probiotics can have beneficial mixtures and probiotic bacteria has been of oral tolerance via controlled exposure to 1–125. infants: a randomized controlled trial. Allergy 2016 Allergy 71 symptoms in ovalbumin-sensitized mice: a bacterial strain 3. Andrew J, Gary H. The microbiome and regulation of mucosal (2016) 701–710. comparative study. Int Arch All IMmunol 2010; 151:107-117. effects in infants at risk of, or living with a logical next step in promoting immune specific peptides of the allergenic protein.16 immunity. John Wiley & Sons Ltd, Immunology 2013; 142: 24–31. 12. Van der Aa LB, Heymans HS, Van Aalderen WM, Sillevis Smitt 20. Schouten B, van Esch BC, Hofman GA, van Doorn S A, Knol J, 11–14 4. Prescott SL. Early-life environmental determinants of JH, Knol J Ben Amor K, Goossens DA, Sprikkelman AB and Nauta AJ, et al. Cow milk allergy symptoms are reduced in mice food allergies. system development and balanced gut allergic disease and the wider pandemic of inflammatory the Synbad Study Group. Effect of a new synbiotic mixture fed dietary synbiotics during oral sensitization with whey. J microbiota as part of strategies for the Recognizing the importance of a balanced noncommunicable diseases. Journal of Allergy and Clinical on atopic dermatitis in infants: a randomized-controlled trial. Nutr 2009; 139: 1398-403. Immunology 2013; 131(1): 23. Clinical & Experimental Allergy, 40, 795–804. 21. Chin Chua M, Ben-Amor K, Lay C, Neo A et al. Effect of Traditional strategies for the dietary nutritional management of CMA. gut microbiota, and building on the 5. Aitoro R, et al. Gut Microbiota
Load more

Recommended publications
  • Utilization of Synbiotics, Acidifiers, and a Polyanhydride Nanoparticle
    Utilization of Synbiotics, Acidifiers, and a Polyanhydride Nanoparticle Vaccine in Enhancing the Anti-Salmonella Immune Response in Laying Hens Post-Salmonella Challenge Dissertation Presented in Partial Fulfillment of the Requirements for the Degree Doctor of Philosophy in the Graduate School of The Ohio State University By Ashley D. Markazi, M.S. Graduate Program in Animal Sciences The Ohio State University 2018 Dissertation Committee: Ramesh K. Selvaraj, Advisor Michael S. Lilburn, Co-Advisor Renukaradhya Gourapura Lisa Bielke Copyright by Ashley D. Markazi 2018 ABSTRACT Salmonellosis, a zoonotic disease caused by the bacterium Salmonella, is most commonly attributed to the consumption of poultry eggs and meat. The current project examined the effects of drinking water synbiotics, in-feed acidifiers, and a polyanhydride nanoparticle Salmonella vaccine in enhancing the anti-Salmonella immune response and decreasing Salmonella infection in laying hens. The synbiotic experiment was conducted to study the effects of drinking water supplementation of synbiotic product in laying hens with and without a Salmonella challenge. A total of 384 one-day-old layer chicks were randomly distributed to the drinking water synbiotic supplementation or control groups. At 14 wk of age, the birds were vaccinated with a Salmonella vaccine, resulting in a 2 (control and synbiotic) X 2 (non-vaccinated and vaccinated) factorial arrangement of treatments. At 24 wk of age, half of the birds in the vaccinated groups and all the birds that were not vaccinated were challenged with Salmonella Enterica serotype Enteritidis, resulting in a 3 (vaccinated, challenged, vaccinated+challenged) X 2 (control and synbiotic) factorial arrangement. At 8 d post-Salmonella challenge, synbiotic supplementation decreased (P = 0.04) cecal S.
    [Show full text]
  • The International Scientific Association for Probiotics and Prebiotics (ISAPP) Consensus Statement on the Definition and Scope of Synbiotics
    CONSENSUS STATEMENT OPEN The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of synbiotics Kelly S. Swanson 1 ✉ , Glenn R. Gibson 2, Robert Hutkins3, Raylene A. Reimer 4, Gregor Reid 5, Kristin Verbeke 6,7, Karen P. Scott 8, Hannah D. Holscher 9, Meghan B. Azad 10, Nathalie M. Delzenne 11 and Mary Ellen Sanders 12 Abstract | In May 2019, the International Scientific Association for Probiotics and Prebiotics (ISAPP) convened a panel of nutritionists, physiologists and microbiologists to review the definition and scope of synbiotics. The panel updated the definition of a synbiotic to “a mixture comprising live microorganisms and substrate(s) selectively utilized by host microorganisms that confers a health benefit on the host”. The panel concluded that defining synbiotics as simply a mixture of probiotics and prebiotics could suppress the innovation of synbiotics that are designed to function cooperatively. Requiring that each component must meet the evidence and dose requirements for probiotics and prebiotics individually could also present an obstacle. Rather, the panel clarified that a complementary synbiotic, which has not been designed so that its component parts function cooperatively, must be composed of a probiotic plus a prebiotic, whereas a synergistic synbiotic does not need to be so. A synergistic synbiotic is a synbiotic for which the substrate is designed to be selectively utilized by the co-administered microorganisms. This Consensus Statement further explores the levels of evidence (existing and required), safety, effects upon targets and implications for stakeholders of the synbiotic concept. Notable properties of the gut microbiota include its itself was formed from the Greek prefix ‘syn’, meaning functionality and resilience1.
    [Show full text]
  • PROMITOR® Soluble Fibre and Synbiotics
    PROMITOR® Soluble Fibre and Synbiotics Recent consensus statement released by The International Scientific Association for Probiotics and Prebiotics (ISAPP) provides a definition and scope of synbiotics.1 • Association of academic and industrial scientists with a common interest in generating high-quality, collaborative, multidisciplinary science and guidance • Only scientific organization dedicated specifically to probiotics and prebiotics • Provides an objective, science-based, trusted voice to guide informed choices PREBIOTICS PROBIOTICS A substrate that is selectively utilized Live microorganisms that, when by host microorganisms conferring a administered in adequate amounts, health benefit confer a health benefit on the host SYNBIOTIC Mix of live microorganisms and substrate(s) selectively utilized by host microorganisms for a health benefit Human clinical study evaluates combination of prebiotic PROMITOR® Soluble Fibre and probiotic Lactobacillus rhamnosus, LGG® PROMITOR® Probiotic Health Soluble Fibre + LGG = Synbiotic Benefit(s) Human intervention study with healthy elderly adults (aged 60-80), consumed 12 g/day of PROMITOR® soluble fibre with or without L. rhamnosus GG® for three weeks.2 i. All treatments (fibre alone or with probiotics) provided significant changes in gut microbiota, while a placebo did not ii. Consumption of L. rhamnosus GG® combined with PROMITOR® soluble fibre increased NK cell activity, a marker of innate immunity, compared to baseline in females and the older group iii. In addition, the study showed a decrease of the pro-inflammatory cytokine IL-6 with the dietary intervention of L. rhamnosus GG® combined with PROMITOR® soluble fibre © Tate&Lyle 2021 PROMITOR® Soluble Fibre Overview PROMITOR® Soluble Fibre makes it easy to meet consumer demands for more fibre.
    [Show full text]
  • Synbiotics Reduce Infectious Complications by Improving the Intestinal Milieu and Enhancing the Immune Function in Critically Ill Emergency Surgical Patients
    Original Contribution Kitasato Med J 2013; 43: 17-25 Synbiotics reduce infectious complications by improving the intestinal milieu and enhancing the immune function in critically ill emergency surgical patients Yuichi Kataoka,1 Tomomichi Kan'o,1 Takashi Asahara,2 Koji Nomoto,2 Kazui Soma1 1 Department of Emergency and Critical Care Medicine, Kitasato University School Medicine 2 Yakult Central Institute for Microbiological Research Objective: To determine the effects of synbiotics upon the intestinal milieu, immune response, and infection in critically ill patients. Methods: Thirty-two critically ill patients, who had undergone emergency surgery, were divided into two groups, those who started receiving enteral synbiotics (Lactobacillus casei strain Shirota and Bifidobacterium breve strain Yakult plus galactooligosaccharides; group S, n = 20) and those who did not receive enteral synbiotics (the control, group C, n = 12) within 48 hours of admission to the ICU and continuing for 14 days. Results: Baseline values were comparable between the two groups. NK (natural killer) cell activity and lymphocyte counts significantly increased in group S. C-reactive protein concentrations significantly decreased in both groups. White blood cell counts significantly decreased in group S, but remained unchanged in group C. Group S had more Bifidobacterium and Lactobacillus and less Pseudomonas than group C in the stool samples after the trial. Concentrations of fecal organic, acetic, and propionic acids were significantly greater and the incidences of infectious complications were significantly lower in group S (25% vs. 75%, P < 0.01). The ICU stay was significantly shorter for group S. None of the patients died or developed adverse events. Conclusions: Synbiotics enhanced host immune function in critically ill emergency surgical patients, improved the intestinal milieu, and decreased the incidence of infectious complications.
    [Show full text]
  • Galactooligosaccharide and Mannanoligosaccharide with Or
    Received: 20 October 2016 | Accepted: 31 January 2017 DOI: 10.1111/anu.12553 ORIGINAL ARTICLE Effect of in vitro selected synbiotics (galactooligosaccharide and mannanoligosaccharide with or without Enterococcus faecalis) on growth performance, immune responses and intestinal microbiota of juvenile narrow clawed crayfish, Astacus leptodactylus leptodactylus Eschscholtz, 1823 O. Safari1 | M. Paolucci2 1Department of Fisheries, Faculty of Natural Resources and Environment, Ferdowsi Abstract University of Mashhad, Mashhad, Iran The aim of this study was to determine the best synbiotic combination (based on 2 Department of Sciences and growth and short- chain fatty acids production) between Enterococcus faecalis and Technologies, University of Sannio, Benevento, Italy eight prebiotics. Based on the results of in vitro studies, E. faecalis + galactooligosac- charide (EGOS) and E. faecalis + mannanoligosaccharide (EMOS) were selected as Correspondence Omid Safari, Department of Fisheries, Faculty synbiotics. A 126- day feeding trial was conducted to compare the effects of prebi- of Natural Resources and Environment, otics, probiotic and synbiotics on the growth indices, In vivo ADC of nutrients, di- Ferdowsi University of Mashhad, Mashhad, Iran. gestive enzymes, hemolymph indices and finally, biological responses against 48- hr Email: [email protected] Aeromonas hydrophila exposure challenges of juvenile (4.13 ± 0.12 g) crayfish. The −1 −1 Funding information highest values of SGR (2.19% body weight day ), VFI (2.75% body weight day ), Research & Technology Deputy of Ferdowsi survival rate (96.67%) and the lowest FCR (2.33) were observed in the juvenile cray- University of Mashhad, Grant/Award Number: 39595 fish fed the EGOS-­ diet. The significantly (p < .05) highest means of in vivo ADCOM, in vivo ADCCP, in vivo ADCCF and in vivo ADCGE were measured in crayfish fed the EGOS-­ diet.
    [Show full text]
  • Review Synbiotics“ Combinationof Probiotics and Prebiotics ”
    IOSR Journal of Biotechnology and Biochemistry (IOSR-JBB) ISSN: 2455-264X, Volume 3, Issue 4 (Jul. – Aug. 2017), PP 19-24 www.iosrjournals.org Review Synbiotics“ Combinationof Probiotics And Prebiotics ” *Pavitra Sharma 1, Anuradha Singh2 ,and NupurMathur3. Environmental Microbiology Lab.Department of Zoology, University of Rajasthan, Jaipur-302004, Rajasthan (India) Research Scholar- University of Rajasthan1 Associate Professor - University of Rajasthan2 Associate Professor - University of Rajasthan3 Corresponding Author: Pavitra Sharma Abstract: The principal role offood in a body is to supply required nutrients which provides energy to sustain for physiologicalfunctions and well being. All food typesare functional, consumption of such functional food provides bioactive molecules.Probiotics, prebiotics and synbioticsare importantbioactive components of functional food which have significant role on well being of human and animal.These bioactive components provides one of the possible approach for improving the health image and developing functional products. Discovery of new prebiotic/probiotic/synbiotic functional foods leads to the food industry to renew constantly by introduction of food items with enhanced nutritional value and also with health advantage for consumers. This review provides information regarding healthbenefits of synbiotic food compounds as they provide bioactive componentsfor health. ----------------------------------------------------------------------------------------------------------------------------- ----------
    [Show full text]
  • PROMITOR® Soluble Fibre and Synbiotics PROBIOTICS
    PROMITOR® Soluble Fibre and Synbiotics Recent consensus statement released by The International Scientific Association for Probiotics and Prebiotics (ISAPP) provides a definition and scope of synbiotics.1 • Association of academic and industrial scientists with a common interest in generating high-quality, collaborative, multidisciplinary science and guidance • Only scientific organization dedicated specifically to probiotics and prebiotics • Provides an objective, science-based, trusted voice to guide informed choices PREBIOTICS PROBIOTICS A substrate that is selectively utilized Live microorganisms that, when by host microorganisms conferring a administered in adequate amounts, health benefit confer a health benefit on the host SYNBIOTIC Mix of live microorganisms and substrate(s) selectively utilized by host microorganisms for a health benefit Human clinical study evaluates combination of prebiotic PROMITOR® Soluble Fibre and probiotic Lactobacillus rhamnosus, LGG® PROMITOR® Probiotic Health Soluble Fibre + LGG = Synbiotic Benefit(s) Soluble Fibre Human intervention study with healthy elderly adults (aged 60-80), consumed 12 g/day of PROMITOR® soluble fibre with or without L. rhamnosus GG® for three weeks.2 i. All treatments (fibre alone or with probiotics) provided significant changes in gut microbiota, while a placebo did not ii. Consumption of L. rhamnosus GG® combined with PROMITOR® soluble fibre increased NK cell activity, a marker of innate immunity, compared to baseline in females and the older group iii. In addition, the study showed a decrease of the pro-inflammatory cytokine IL-6 with the dietary intervention of L. rhamnosus GG® combined with PROMITOR® soluble fibre © Tate&Lyle 2021 PROMITOR® Soluble Fibre Overview PROMITOR® Soluble Fibre makes it easy to meet consumer demands for more fibre.
    [Show full text]
  • A Closer Look at Synbiotics a Powerful Combination of Prebiotics and Probiotics
    NUTRITION EXCHANGE A Closer Look at Synbiotics A Powerful Combination of Prebiotics and Probiotics When it comes to the gut microbiota, sometimes it’s not only Prebiotics, such as psyllium, are non-digestible carbohydrates what you are feeding a patient, but also how bacteria and certain that are selectively fermented by beneficial bacteria in the ingredients can work together in a beneficial way.Synbiotics colon. Prebiotics may promote growth and metabolic activity of are a mixture of prebiotics and probiotics that benefit the host beneficial bacterial species.1,2 This may improve microbial balance by improving the survival and implantation of live beneficial in the gastrointestinal (GI) tract and promote production of bacteria in the gastrointestinal tract.1,2 This is achieved by butyrate, the primary fuel source for colonocytes.2,3 selectively stimulating the growth of beneficial bacteria to help Butyrate, the short-chain fatty acid, may confer the following maintain gut health.1,3 GI benefits:2,6,7 2,5 The World Health Organization definesprobiotics as “live • Increase absorption of water and electrolytes microorganisms that when consumed in adequate amounts • Enhance mucosal blood flow confer a health benefit on the host.”4 • Nourish gut epithelium to promote cell turnover • Modification of gut microbiota • Enhance mucosal size and stability through increasing • Compete with pathogenic bacteria for binding to gut mucosa microvilli size • Strengthening of gut epithelial barrier • Reduce microbial adhesion of pathogenic bacteria • Modulation of host immune system • Anti-inflammatory action to increase healing after an insult • Production of short-chain fatty acids and decrease gut permeability • Enhance immune system function The health benefits of probiotics are strain specific.
    [Show full text]
  • Probiotics, Prebiotics and Synbiotics—A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases?
    International Journal of Molecular Sciences Review Probiotics, Prebiotics and Synbiotics—A Promising Strategy in Prevention and Treatment of Cardiovascular Diseases? Beata Olas Department of General Biochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Pomorska 141/3, 90-236 Lodz, Poland; [email protected]; Tel./Fax: +48-42-635-4484 Received: 19 November 2020; Accepted: 17 December 2020; Published: 20 December 2020 Abstract: Recent evidence suggests that probiotics, prebiotics and synbiotics may serve as important dietary components in the prevention (especially) and treatment of cardiovascular diseases (CVD), but the recommendations for their use are often based on brief reports and small clinical studies. This review evaluates the current literature on the correlation between CVD and probiotics, prebiotics and synbiotics. Although research on probiotics, prebiotics and synbiotics has grown exponentially in recent years, particularly regarding the effect of probiotics on CVD, their mechanisms have not been clearly defined. It has been proposed that probiotics lower cholesterol levels, and may protect against CVD, by increasing bile salt synthesis and bile acid deconjugation. Similar effects have also been observed for prebiotics and synbiotics; however, probiotics also appear to have anti-oxidative, anti-platelet and anti-inflammatory properties. Importantly, probiotics not only have demonstrated effects in vitro and in animal models, but also in humans, where supplementation with probiotics decreases
    [Show full text]
  • Synbiotic Preparation with Lactic Acid Bacteria and Inulin As A
    a ISSN 0101-2061 Food Science and Technology DDOI http://dx.doi.org/10.1590/1678-457X.26216 Synbiotic preparation with Lactic acid bacteria and inulin as a functional food: In vivo evaluation of microbial activities, and preneoplastic aberrant crypt foci Chaiyavat CHAIYASUT1, Thanawat PATTANANANDECHA1, Sasithorn SIRILUN1, Prasit SUWANNALERT2, Sartjin PEERAJAN3, Bhagavathi Sundaram SIVAMARUTHI1* Abstract Host microbiome and metabolome are associated with the incidence of colorectal cancer (CC), one of the major health problems in developed countries. The pro and prebiotic supplementation helps to improve the host health. Inulin is one such prebiotic used for the enhancement of naïve probiotic bacterial population. This paper explains the impact of inulin (PRE) extracted from Jerusalem artichoke (JA), Lactobacillus plantarum HII11 (PRD), and synbiotic (SYN; inulin + L. plantarum HII11) preparation on Azoxymethane mediated CC induced rat model with respect to changes in microbial load, microbial enzymes, and preneoplastic aberrant crypt foci. The results suggested that the PRE and SYN supplementation effectively reduced the selected pathogenic bacteria (Salmonella spp., and Escherichia coli), microbial enzymes and increased the probiotic load. The intervention of SYN significantly reduced the colonic ACF in CC model. The study results revealed that the supplementation of SYN diet (inulin and L. plantarum HII11) protects the ADM-mediated colon cancer induced host. Keywords: inulin; L. plantarum; probiotic; prebiotic; synbiotic. Practical Application: The study results help to develop functional food to improve the human health. 1 Introduction Colorectal cancer (CC) is one of the major health problems the growth and/ or activity of probiotic bacteria, resisting with the vast incidence in developed countries.
    [Show full text]
  • Prebiotics and Synbiotics: Dietary Strategies for Improving Gut Health Janina A
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln Faculty Publications in Food Science and Food Science and Technology Department Technology 2016 Prebiotics and synbiotics: Dietary strategies for improving gut health Janina A. Krumbeck University of Nebraska-Lincoln, [email protected] Maria X. Maldonado-Gomez University of Nebraska – Lincoln, [email protected] Amanda E. Ramer-Tait University of Nebraska-Lincoln, [email protected] Robert W. Hutkins University of Nebraska-Lincoln, [email protected] Follow this and additional works at: http://digitalcommons.unl.edu/foodsciefacpub Part of the Food Microbiology Commons Krumbeck, Janina A.; Maldonado-Gomez, Maria X.; Ramer-Tait, Amanda E.; and Hutkins, Robert W., "Prebiotics and synbiotics: Dietary strategies for improving gut health" (2016). Faculty Publications in Food Science and Technology. 232. http://digitalcommons.unl.edu/foodsciefacpub/232 This Article is brought to you for free and open access by the Food Science and Technology Department at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Faculty Publications in Food Science and Technology by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. Published in Current Opinion in Gastroenterology 32 (2016), pp. 110–119. doi:10.1097/MOG.0000000000000249 Copyright © 2016 Wolters Kluwer Health, Inc. Used by permission. digitalcommons.unl.edu Prebiotics and synbiotics: Dietary strategies for improving gut health Janina A. Krumbeck,1, 2 Maria X. Maldonado-Gomez,1 Amanda E. Ramer-Tait,1 and Robert W. Hutkins1 1 Department of Food Science and Technology, University of Nebraska–Lincoln, Lincoln, Nebraska, USA 2 School of Biological Sciences, University of Nebraska–Lincoln, Lincoln, Nebraska, USA Corresponding author — Robert W.
    [Show full text]
  • Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients
    nutrients Review Gut Microbiota and Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients Kentaro Shimizu * , Masahiro Ojima and Hiroshi Ogura Department of Traumatology and Acute Critical Medicine, Osaka University Graduate School of Medicine, Osaka 565-0871, Japan; [email protected] (M.O.); [email protected] (H.O.) * Correspondence: [email protected] Abstract: Patients suffering from critical illness have host inflammatory responses against injuries, such as infection and trauma, that can lead to tissue damage, organ failure, and death. Modulation of host immune response as well as infection and damage control are detrimental factors in the management of systemic inflammation. The gut is the motor of multiple organ failure following injury, and it is recognized that gut dysfunction is one of the causative factors of disease progression. The gut microbiota has a role in maintaining host immunity, and disruption of the gut microbiota might induce an immunosuppressive condition in critically ill patients. Treatment with probiotics and synbiotics has been reported to attenuate systemic inflammation by maintaining gut microbiota and to reduce postoperative infectious complications and ventilator-associated pneumonia. The administration of prophylactic probiotics/synbiotics could be an important treatment option for preventing infectious complications and modulating immunity. Further basic and clinical research is needed to promote intestinal therapies for critically ill patients. Citation: Shimizu, K.; Ojima, M.; Keywords: microbiota; gut; ICU; immune; ventilator; inflammation; probiotics; prebiotics; Ogura, H. Gut Microbiota and synbiotics; critically Probiotics/Synbiotics for Modulation of Immunity in Critically Ill Patients. Nutrients 2021, 13, 2439.
    [Show full text]